Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pediatric Delirium
Sponsor: University of Massachusetts, Worcester
Summary
Preventing emergent delirium in pediatric ambulatory surgery through preoperative use of intra-nasal Dexmedetomidine and oral Midazolam.
Official title: Prevention of Emergence Delirium in Pediatric Ambulatory Surgery: Single Blinded Randomized Control Study Comparing Intra-nasal Dexmedetomidine With Oral Midazolam.
Key Details
Gender
All
Age Range
3 Months - 9 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2021-04-27
Completion Date
2026-04-05
Last Updated
2025-07-25
Healthy Volunteers
Yes
Conditions
Interventions
Intra-nasal Dexmedetomidine
Subjects will receive Dexmedetomidine intra-nasally in the preoperative area. It will be administered at a dose of 1 mcg/kg, approximately 15-25 minutes before entering the operating room.
Oral Midazolam
Subjects will receive Midazolam orally in the preoperative area. It will be administered at a dose of 0.5 mg/kg (with a maximum dose of 20 mg), approximately 10-15 minutes before entering the operating room.
Locations (1)
University of Massachusetts Medical School
Worcester, Massachusetts, United States